Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Featured News - Ofloxacin > Tongliao Kaiyuan Biological Company invested in a new rifamycin biological fermentation series product project
— Share —

Tongliao Kaiyuan Biological Company invested in a new rifamycin biological fermentation series product project

healthoo 2021-07-07
The annual output of this project is 400 tons of rifamycin S sodium salt, 100 tons of rifamycin S acid, 200 tons of triformylrifamycin SV, and 250 tons of 1-amino-4-methylpiperazine. The main by-products are Soybean oil.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.